146827-58-9Relevant articles and documents
Studies directed toward the design of orally active renin inhibitors. 2. Development of the efficacious, bioavailable renin inhibitor (2S)-2-benzyl- 3-[[(1-methylpiperazin-4-yl)sulfonyl]propionyl]-3-thiazol-4-yl-L-alanine amide of (2S,3R,4S)-2-amino-1-cyc
Rosenberg,Spina,Condon,Polakowski,Yao,Kovar,Stein,Cohen,Barlow,Klinghofer,Egan,Tricarico,Perun,Baker,Kleinert
, p. 460 - 467 (1993)
Employing a set of empirical guidelines for the design of well-absorbed renin inhibitors, we have followed two strategies to improve potency while maintaining bioavailability. One process involved incorporation of an extended N-terminal residue bearing a
